{"gene":"HK2","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2012,"finding":"Under hypoxia, TIGAR protein relocalizes to mitochondria and forms a direct complex with HK2, resulting in an increase in HK2 hexokinase activity. Mitochondrial localization of TIGAR depends on mitochondrial HK2 and HIF1α activity. TIGAR's fructose-2,6-bisphosphatase activity is independent of HK2 binding, but both activities contribute to limiting mitochondrial ROS and protecting from cell death.","method":"Co-immunoprecipitation, subcellular fractionation, mitochondrial localization assays, ROS measurement, cell death assays in hypoxic cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with functional consequence (HK2 activity increase), subcellular fractionation, multiple orthogonal methods in a single rigorous study","pmids":["23185017"],"is_preprint":false},{"year":2012,"finding":"Mitochondrial HK2 interacts directly with PEA15 (phosphoprotein enriched in astrocytes) to form a molecular switch governing cell fate: HK2 + PEA15 inhibits apoptosis after hypoxia, whereas HK2 without PEA15 under glucose deprivation accelerates apoptosis. HK2 thus functions both as a cytoprotective molecule and as a glucose availability sensor that triggers apoptosis under metabolic stress.","method":"Co-immunoprecipitation, genetic overexpression/knockdown, cell death assays under hypoxia and glucose deprivation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying direct interactor, multiple functional readouts (apoptosis induction/inhibition), two orthogonal experimental conditions in one study","pmids":["22233811"],"is_preprint":false},{"year":2015,"finding":"HK2 is degraded by chaperone-mediated autophagy (CMA) and is a bona fide CMA substrate. HK2 degradation by CMA is regulated by glucose availability (reduced glucose increases CMA-mediated HK2 degradation). Excessive CMA activation, triggered by perturbation of FLT3 signaling, leads to HK2 degradation, metabolic catastrophe, and cancer cell death.","method":"Proteome analysis identifying CMA substrates, lysosomal fraction assays, genetic manipulation of CMA pathway components, glucose availability modulation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — proteomics-based substrate identification with functional validation using multiple genetic and pharmacological approaches in a single rigorous study","pmids":["26323688"],"is_preprint":false},{"year":2015,"finding":"HK2 facilitates autophagy in response to glucose deprivation (substrate deprivation) to protect cardiomyocytes, functioning as a molecular switch from glycolysis to autophagy to ensure cellular energy homeostasis under starvation conditions.","method":"Glucose deprivation experiments in cardiomyocytes, autophagy flux assays, HK2 overexpression/knockdown with cellular survival readouts","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined cellular role with specific phenotypic readout (autophagy induction), single lab, limited mechanistic detail in abstract","pmids":["26075878"],"is_preprint":false},{"year":2023,"finding":"STING directly targets HK2 to block its hexokinase enzymatic activity, thereby restricting aerobic glycolysis independent of STING's innate immune signaling function. STING inhibition of HK2 promotes antitumor immunity in vivo.","method":"In vitro hexokinase activity assays, genetic manipulation of STING expression, in vivo tumor models, correlative analysis in human colorectal carcinoma samples","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — enzymatic activity assay directly demonstrating STING blocks HK2 hexokinase activity, complemented by in vivo validation, published in high-tier journal","pmids":["37443289"],"is_preprint":false},{"year":2021,"finding":"After mitochondrial translocation under hypoxia, Drp1 promotes excessive mPTP opening through a pathway involving HK2: LRRK2 is recruited and its kinase activity is inhibited by mitochondrial Drp1, causing HK2 inactivation at Thr-473 and its dissociation from the mitochondrial membrane, which disrupts mPTP structure and causes mPTP overopening.","method":"Colocalization assays, co-immunoprecipitation, phosphorylation site identification (Thr-473), mitochondrial fractionation, mPTP opening assays in hypoxic cells","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, phosphorylation site mapping, and functional mPTP assays in a single study; single lab","pmids":["34741026"],"is_preprint":false},{"year":2019,"finding":"GSK-3β-mediated phosphorylation of mitochondrial VDAC induces dissociation of HK2 from VDAC/mitochondria, leading to glycolytic inhibition and mitochondrial-mediated apoptosis. The flavonoid GL-V9 triggers this mechanism by activating GSK-3β and inhibiting AKT.","method":"Co-immunoprecipitation of HK2-VDAC complex, Western blot for phospho-VDAC, glycolysis assays, apoptosis assays, in vivo xenograft","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating HK2-VDAC interaction, phosphorylation mechanism, multiple functional readouts; single lab","pmids":["31669347"],"is_preprint":false},{"year":2018,"finding":"Zinc and p53 disrupt mitochondrial binding of HK2 in prostate cancer cells by promoting phosphorylation of VDAC1, mediated through Akt inhibition and GSK3β activation, leading to HK2 mitochondrial dissociation.","method":"Subcellular fractionation, Western blot for phospho-VDAC1, co-immunoprecipitation, Akt inhibition and GSK3β activation assays, xenograft model","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway defined with phosphorylation evidence and subcellular localization readout; single lab, multiple methods","pmids":["30528266"],"is_preprint":false},{"year":2009,"finding":"Ischemic preconditioning (IPC) causes cellular redistribution of HKII (but not HKI): decreased cytosolic HKII during ischemia and increased mitochondrial HKII activity before ischemia and during reperfusion. IPC-mediated decreased cytosolic HK activity during ischemia is explained by decreased HKII protein content in the cytosolic fraction.","method":"Subcellular fractionation (mitochondrial, cytosolic, microsomal fractions), hexokinase activity assays, Western blot for HKII protein content in isolated Langendorff-perfused rat hearts","journal":"Journal of applied physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular fractionation with activity assays across multiple time points; single lab, rigorous experimental design","pmids":["19228992"],"is_preprint":false},{"year":2017,"finding":"TNFα triggers IKK-mediated YAP phosphorylation and activation in breast cancer cells. YAP and p65 interact physically, and the YAP/TEAD and p65 complex synergistically regulates HK2 transcription to promote TNFα-induced cell migration.","method":"Co-immunoprecipitation of YAP and p65, chromatin immunoprecipitation (ChIP) showing YAP/TEAD and p65 binding to HK2 promoter, migration assays, reporter assays","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP establishing transcriptional mechanism at HK2 promoter; single lab with two orthogonal methods","pmids":["28945218"],"is_preprint":false},{"year":2022,"finding":"KLF14 transcriptionally inhibits HK2 expression in macrophages. KLF14 deletion leads to increased glycolysis (via HK2 upregulation) and increased inflammatory cytokine secretion. Pharmacological KLF14 activation reduces HK2 expression, decreases glycolysis, and confers protection against sepsis.","method":"KLF14 knockout mice, siRNA knockdown, promoter assays, cytokine measurement, glycolysis assays, in vivo endotoxemia/sepsis models","journal":"Cellular & molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in vivo model combined with in vitro transcriptional mechanism; single lab, multiple methods","pmids":["34983946"],"is_preprint":false},{"year":2005,"finding":"SREBP-1 binds to the HK2 (HKII) promoter in vivo in liver, adipose tissue, and skeletal muscle (demonstrated by chromatin immunoprecipitation), and regulates HKII expression in response to nutritional status (fasting/refeeding). SREBP-1 thus plays a major role in nutritional regulation of glucose metabolism via HKII.","method":"Chromatin immunoprecipitation (ChIP) in rat tissues, mRNA and protein expression analysis during fasting/refeeding","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo ChIP demonstrating direct SREBP-1 binding to HKII promoter in multiple tissues; single lab","pmids":["15627654"],"is_preprint":false},{"year":2012,"finding":"PPARγ transcription factor binds directly to the HK2 (hexokinase 2) promoter to activate HK2 transcription in PTEN-null fatty liver. HK2 expression, along with PKM2, is under control of Akt2 kinase through PPARγ in this context.","method":"Chromatin immunoprecipitation (ChIP) demonstrating PPARγ binding to HK2 promoter, genetic models (PTEN-null liver, Akt2 knockout), transcriptional reporter assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP evidence for PPARγ at HK2 promoter in vivo with genetic validation; single lab","pmids":["22334075"],"is_preprint":false},{"year":2002,"finding":"AMPK signaling activates transcription of the HKII gene in rat skeletal muscle. Single-leg AICAR infusion (activating AMPK-α2) induced a dose-dependent 2–4-fold increase in HKII transcription specifically in muscle of the infused leg, establishing AMPK as a transcriptional regulator of HKII.","method":"Single-leg arterial infusion of AICAR in conscious rats, AMPK activity assays, HKII mRNA quantification in red and white skeletal muscle","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with dose-response, tissue-specific effect confirming AMPK-HKII transcriptional link; single lab","pmids":["12388122"],"is_preprint":false},{"year":2007,"finding":"Calcium signaling via calcineurin and CaMK pathways regulates HKII mRNA expression in skeletal muscle. Ionomycin treatment increased HKII mRNA ~2-fold; cyclosporin A (calcineurin inhibitor) and KN-62 (CaMK inhibitor) reduced ionomycin-induced HKII transcription, establishing calcineurin and CaMK as upstream regulators of HKII.","method":"Pharmacological inhibition (cyclosporin A, KN-62), ionomycin stimulation, electrical stimulation of isolated muscle, mRNA quantification in primary rat skeletal muscle cells and EDL muscle","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological inhibitors used in both cell culture and ex vivo muscle; single lab, consistent results across two experimental systems","pmids":["17516843"],"is_preprint":false},{"year":2022,"finding":"HK2 acts as a protein kinase (non-canonical activity) and phosphorylates IκBα at Thr291 under high glucose conditions in breast cancer cells, leading to rapid IκBα degradation, NF-κB activation, and transcriptional upregulation of PD-L1, thereby promoting immune evasion.","method":"Phosphorylation assays, mutagenesis of IκBα Thr291, Co-IP, NF-κB reporter assays, PD-L1 expression analysis, immunohistochemistry in human breast cancer specimens","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific phosphorylation identified with mutagenesis and functional consequence (NF-κB/PD-L1); single lab, multiple methods","pmids":["37377974"],"is_preprint":false},{"year":2020,"finding":"CSN5 (COP9 signalosome subunit 5) stabilizes HK2 protein through its deubiquitinase function, attenuating ubiquitin-proteasome-mediated HK2 degradation. CSN5 knockdown decreases HK2 protein level and glycolytic flux; re-expression of HK2 rescues glycolysis. Curcumin inhibition of CSN5 kinase activity decreases HK2 expression.","method":"Co-immunoprecipitation, ubiquitination assays, glycolysis flux measurements, HK2 rescue experiments, in vivo tumor models","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deubiquitination mechanism established with Co-IP and ubiquitination assays plus functional rescue; single lab","pmids":["31991125"],"is_preprint":false},{"year":2023,"finding":"TRIM36 E3 ubiquitin ligase directly binds HK2 and promotes its degradation via K48-linked ubiquitination. TRIM36-mediated HK2 ubiquitination reduces HK2 protein, suppresses glycolysis, decreases GPx4 expression, and activates ferroptosis to inhibit neuroendocrine differentiation in prostate cancer.","method":"Co-immunoprecipitation, ubiquitination assays specifying K48-linkage, proteomic analysis, ferroptosis assays, HK2 knockdown/overexpression","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — linkage-specific ubiquitination identified with Co-IP and functional downstream consequence; single lab","pmids":["36799474"],"is_preprint":false},{"year":2025,"finding":"OTUD1 deubiquitinase directly binds to the C-terminal domain of HK2 via its Ala-rich domain and selectively cleaves K63-linked polyubiquitin chains on HK2, promoting HK2 dissociation from mitochondria. Mitochondrial HK2 dissociation activates the NLRP3 inflammasome and pyroptosis in microglia, causing neuroinflammation in sepsis-associated encephalopathy.","method":"Molecular docking, co-immunoprecipitation, 3D confocal microscopy, OTUD1 knockout mice, primary microglia experiments, behavioral tests, Western blot for K63-ubiquitin linkage","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — linkage-specific deubiquitination with domain mapping and in vivo KO validation; single lab, multiple orthogonal methods","pmids":["40500776"],"is_preprint":false},{"year":2022,"finding":"HK2 undergoes circadian oscillation in trastuzumab-resistant gastric cancer cells, regulated by a transcriptional complex composed of PPARγ and the core clock gene PER1. Higher HK2-dependent glycolysis at ZT6 and lower at ZT18 is controlled by the BMAL1-CLOCK-PER1-HK2 axis. Silencing PER1 disrupts HK2 circadian rhythm and reverses trastuzumab resistance.","method":"In vivo and in vitro circadian glycolysis assays, PER1 silencing, ChIP for transcriptional complex at HK2 promoter, trastuzumab resistance models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating PPARγ/PER1 complex at HK2 promoter, with circadian functional readout in vivo and in vitro; single lab","pmids":["35255118"],"is_preprint":false},{"year":2022,"finding":"UBR7 E3 ligase monoubiquitinates histone H2B at K120 (H2BK120ub), which regulates Keap1 promoter binding, thereby controlling Keap1 expression and downstream Nrf2/Bach1/HK2 signaling. UBR7 loss de-represses HK2 expression to promote aerobic glycolysis and HCC tumorigenesis.","method":"RNAi screening, ChIP showing H2BK120ub at Keap1 promoter, Western blot, glycolysis assays, in vivo tumor models","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-validated epigenetic mechanism linking UBR7 to HK2 through Keap1/Nrf2/Bach1 axis; single lab","pmids":["36419136"],"is_preprint":false},{"year":2020,"finding":"FOXE1 transcription factor directly binds to the HK2 promoter and negatively regulates HK2 transcription, thereby suppressing aerobic glycolysis in colorectal cancer cells.","method":"ChIP assay demonstrating FOXE1 binding to HK2 promoter, luciferase reporter assays, gene knockdown/overexpression, glycolysis assays","journal":"Cell communication and signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP evidence for FOXE1 at HK2 promoter with functional transcriptional consequence; single lab","pmids":["31918722"],"is_preprint":false},{"year":2024,"finding":"CCT6A interacts with STAT1 protein via co-immunoprecipitation, forming a complex that enhances STAT1 stability by protecting it from ubiquitin-mediated degradation. Stabilized STAT1 then facilitates transcription of HK2, stimulating aerobic glycolysis in lung adenocarcinoma.","method":"Co-immunoprecipitation, ChIP assay, transcriptomic sequencing, LC-MS/MS, gene silencing with phenotypic readouts","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP establishing CCT6A/STAT1/HK2 transcriptional axis; single lab with two orthogonal methods","pmids":["38750462"],"is_preprint":false},{"year":2023,"finding":"ATF4 directly binds to the HK2 promoter region and interacts with HIF-1α, stabilizing HIF-1α through ubiquitination modification in response to LPS. The ATF4-HIF-1α-HK2-glycolysis axis activates pro-inflammatory macrophage response via mTOR.","method":"Promoter binding assays, co-immunoprecipitation of ATF4-HIF-1α, ubiquitination assays, glycolysis measurements, cytokine assays, Atf4 knockdown/overexpression","journal":"Clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter binding plus Co-IP establishing the ATF4-HIF-1α-HK2 axis; single lab","pmids":["37481013"],"is_preprint":false},{"year":2022,"finding":"Glutamate from nerve cells activates NMDAR on pancreatic cancer cells, causing Ca2+ influx and CaMKII/ERK-MAPK pathway activation, which promotes METTL3 transcription. METTL3 then upregulates HK2 expression through N6-methyladenosine (m6A) modification of HK2 mRNA, enhancing glycolysis and perineural invasion.","method":"Ca2+ influx assays, pathway inhibition, METTL3 knockdown/overexpression, m6A sequencing/modification assays, HK2 expression analysis, in vivo sciatic nerve invasion model","journal":"Pharmacological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — m6A modification of HK2 mRNA established with sequencing; mechanistic pathway defined with multiple pharmacological inhibitors; single lab","pmids":["36403721"],"is_preprint":false},{"year":2025,"finding":"NAT10 RNA acetyltransferase stimulates ac4C modification at the junction of the CDS and 3'UTR of HK2 mRNA, enhancing HK2 mRNA stability and protein expression to activate glycolysis and drive gastric tumorigenesis. Glucose deprivation activates autophagy-lysosome degradation of NAT10, reducing ac4C modification of HK2.","method":"Dot blotting, immunofluorescence, co-immunoprecipitation, high-throughput sequencing (ac4C-seq), conditional knockout mouse model, organoids, GC xenografts, PET/CT imaging","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — epitranscriptomic modification (ac4C) of HK2 mRNA established with sequencing plus multiple orthogonal methods and in vivo validation including CKO mouse and organoids","pmids":["39990211"],"is_preprint":false},{"year":2022,"finding":"E6E7 HPV oncogenes activate GSK3β transcription in cervical cancer cells; GSK3β promotes ubiquitination-proteasomal degradation of FTO; reduced FTO retains HK2 pre-mRNA in the nucleus, preventing maturation to cytoplasmic HK2 mRNA, thereby upregulating HK2 protein expression.","method":"qRT-PCR for pre-mRNA vs. mature mRNA, Western blot, nuclear/cytoplasmic fractionation, overexpression of E6E7 and FTO, ubiquitination assays","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pre-mRNA nuclear retention mechanism supported by subcellular fractionation and multiple molecular tools; single lab","pmids":["36075458"],"is_preprint":false},{"year":2023,"finding":"HK2 translocates to the nucleus in gastric cancer cells under GCMSC-derived IL-8 stimulation via AKT-mediated phosphorylation. Phosphorylated nuclear HK2 promotes PD-L1 transcription by binding to HIF-1α.","method":"Subcellular fractionation, Western blot, co-immunoprecipitation of HK2 and HIF-1α, AKT inhibition experiments, PD-L1 reporter assays","journal":"Gastric cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear localization with functional consequence (PD-L1 transcription) established via fractionation and Co-IP; single lab","pmids":["37300724"],"is_preprint":false},{"year":2022,"finding":"ZNF281 directly binds to the 5'-GGCGGCGGGCGG-3' motif within the HK2 promoter and transcriptionally represses HK2 expression, reducing HK2-PINK1/Parkin signaling-mediated mitophagy and promoting hepatocyte senescence in alcoholic liver disease.","method":"ChIP assay, promoter binding assays identifying specific binding motif, siRNA knockdown, adeno-associated virus ZNF281 shRNA in vivo, mitophagy assays","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with specific motif identification and in vivo validation; single lab, functional mitophagy readout","pmids":["36514923"],"is_preprint":false},{"year":2024,"finding":"In renal ischemia-reperfusion injury, HK2-mediated glycolysis generates lactate that promotes H3K18 lactylation, which in turn is enriched at the HK2 promoter (ChIP) and upregulates HK2 expression, forming a positive feedback loop. AST-120 breaks this loop by suppressing HK2.","method":"HK2 knockout mice, Seahorse analysis, chromatin immunoprecipitation for H3K18 lactylation at HK2 promoter, Western blotting, H/R cell model","journal":"Molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating histone lactylation at HK2 promoter with HK2 KO validation; single lab","pmids":["39217289"],"is_preprint":false},{"year":2024,"finding":"In endothelial cells, Foxp1 transcriptionally represses Hif1α, which in turn represses Hk2 transcription. Foxp1 deletion in ECs increases Hif1α→Hk2 expression, hyperglycolysis, and tumor angiogenesis. Genetic deletion of EC-Hif1α or siRNA knockdown of Hif1α/Hk2 delivered via RGD-peptide nanoparticles reduces tumor EC hyperglycolysis and restricts angiogenesis.","method":"EC-specific Foxp1/Hif1α knockout mice, nanoparticle-mediated siRNA delivery, angiogenesis assays, retinal and tumor vascularization studies, TCGA analysis","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo establishing Foxp1-Hif1α-Hk2 pathway in ECs with functional angiogenesis readout; single lab","pmids":["39083899"],"is_preprint":false},{"year":2018,"finding":"Dhcr24 overexpression activates the PI3K/Akt/HKII pathway in cardiomyocytes, leading to reduced Bax translocation and inhibition of mitochondrial-dependent apoptosis. Knockdown of Dhcr24 reduces PI3K/Akt/HKII pathway activation. HKII inhibition partially reverses the anti-apoptotic effect of Dhcr24 in H9c2 cells.","method":"Transgenic overexpression, Dhcr24 knockdown, Western blot, TUNEL assay, HKII inhibitor (2-DG) in H9c2 cells, PI3K inhibitor","journal":"Animal models and experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic overexpression and inhibitor epistasis placing HKII downstream of Dhcr24/Akt with apoptosis readout; single lab","pmids":["30891546"],"is_preprint":false},{"year":2023,"finding":"Mitochondria-bound HK2 (requiring intact N-terminal mitochondrial binding motif) regulates the invasive and migratory phenotype of RA fibroblast-like synoviocytes (FLS). Overexpression of full-length HK2 promotes FLS invasion/migration after PDGF stimulation; HK2 lacking its mitochondrial binding motif (HK2ΔN) reverses this. Tofacitinib but not methotrexate promotes HK2 dissociation from mitochondria.","method":"Adenoviral overexpression of FL-HK2 vs. HK2ΔN, confocal microscopy for localization, migration/invasion assays, in vivo arthritis model, scRNA-seq data analysis","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain deletion experiment (HK2ΔN) directly linking mitochondrial localization to FLS invasive phenotype; in vivo validation; single lab","pmids":["37529037"],"is_preprint":false},{"year":2024,"finding":"TRPV4 calcium channel activation induces Drp1 mitochondrial translocation via Ca2+-CaMKII signaling, which subsequently causes HK2 dissociation from the mitochondrial membrane, leading to mPTP overopening, mitochondrial dysfunction, and chondrocyte pyroptosis in osteoarthritis.","method":"Ca2+ measurement, CaMKII signaling assays, Drp1 translocation assays, HK2 mitochondrial fractionation, mPTP opening assays, TRPV4 inhibitor in ACLT mouse model","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway defined with multiple signaling assays and in vivo mouse model; single lab","pmids":["37506502"],"is_preprint":false}],"current_model":"HK2 (hexokinase II) catalyzes the first committed step of glycolysis (glucose → glucose-6-phosphate) and is regulated transcriptionally by SREBP-1, PPARγ, AMPK, KLF14, FOXE1, and calcium/calcineurin/CaMK pathways; its protein stability is controlled by CMA-mediated lysosomal degradation, COP9 signalosome (CSN5) deubiquitination, TRIM36- and UBR7-mediated K48-linked ubiquitination, and OTUD1-mediated K63-linked deubiquitination; mitochondrial localization (via the N-terminal binding to VDAC) is dynamically regulated by Akt/GSK3β-mediated VDAC phosphorylation and governs both cell survival (via interaction with PEA15 under hypoxia) and apoptosis induction (under glucose deprivation); beyond canonical glycolysis, HK2 exerts non-canonical protein kinase activity (phosphorylating IκBα at Thr291 to activate NF-κB/PD-L1), acts as a molecular switch to induce autophagy during substrate deprivation, and its mitochondrial dissociation (triggered by Drp1, OTUD1, or pharmacological agents) activates the NLRP3 inflammasome and mPTP overopening; STING directly blocks HK2 enzymatic activity to restrict aerobic glycolysis and promote antitumor immunity."},"narrative":{"mechanistic_narrative":"HK2 catalyzes the committed, glucose-6-phosphate-generating step of glycolysis and serves as a metabolic hub whose subcellular localization, abundance, and even non-enzymatic activities couple glucose availability to cell fate [PMID:22233811, PMID:19228992]. A defining feature is its N-terminal binding to mitochondria via VDAC: this association is dynamically controlled by Akt/GSK3β signaling, where GSK3β-mediated VDAC phosphorylation drives HK2 dissociation, glycolytic inhibition, and mitochondrial apoptosis [PMID:31669347, PMID:30528266]. At the mitochondrion HK2 forms a molecular switch that determines survival versus death—partnering with PEA15 to suppress apoptosis after hypoxia while triggering apoptosis under glucose deprivation [PMID:22233811]—and its enzymatic activity is potentiated by hypoxia-driven recruitment of TIGAR, which limits mitochondrial ROS [PMID:23185017]. HK2 dissociation from mitochondria, induced by Drp1/CaMKII signaling or by OTUD1-mediated K63 deubiquitination, disrupts the mitochondrial permeability transition pore and activates the NLRP3 inflammasome and pyroptosis [PMID:34741026, PMID:40500776, PMID:37506502]. HK2 protein abundance is tightly set by competing degradation routes, including chaperone-mediated autophagy responsive to glucose levels [PMID:26323688], CSN5/OTUD1 deubiquitination [PMID:31991125, PMID:40500776], and TRIM36/UBR7-linked ubiquitin-proteasome turnover [PMID:36799474, PMID:36419136]. HK2 transcription integrates an extensive regulatory network spanning nutritional and stress signaling (SREBP-1, AMPK, PPARγ, calcium/calcineurin-CaMK, ATF4/HIF-1α) and repressive factors (KLF14, FOXE1, ZNF281, Foxp1) [PMID:15627654, PMID:12388122, PMID:22334075, PMID:17516843, PMID:37481013, PMID:34983946, PMID:31918722, PMID:36514923, PMID:39083899], and its mRNA is further controlled by epitranscriptomic marks (m6A via METTL3, ac4C via NAT10) and nuclear pre-mRNA retention [PMID:36403721, PMID:39990211, PMID:36075458]. Beyond catalysis, HK2 has non-canonical functions: it acts as a protein kinase phosphorylating IκBα at Thr291 to activate NF-κB and induce PD-L1 [PMID:37377974], translocates to the nucleus where, phosphorylated by AKT, it binds HIF-1α to drive PD-L1 transcription [PMID:37300724], and functions as a switch from glycolysis to autophagy under substrate deprivation [PMID:26075878]. STING directly inhibits HK2 enzymatic activity to restrict aerobic glycolysis and promote antitumor immunity, independent of innate immune signaling [PMID:37443289].","teleology":[{"year":2005,"claim":"Established that HK2 transcription is directly wired to nutritional state, defining the lipogenic transcription factor SREBP-1 as a direct activator of the HK2 promoter in metabolic tissues.","evidence":"In vivo ChIP and fasting/refeeding expression analysis in rat liver, adipose, and muscle","pmids":["15627654"],"confidence":"Medium","gaps":["Does not address protein-level or localization regulation","Co-regulation with other nutrient-responsive factors not resolved"]},{"year":2009,"claim":"Showed that HK2, uniquely among hexokinases, redistributes between cytosol and mitochondria during ischemic preconditioning, framing subcellular localization as a regulated functional variable.","evidence":"Subcellular fractionation and hexokinase activity assays in Langendorff-perfused rat hearts","pmids":["19228992"],"confidence":"Medium","gaps":["Molecular trigger of redistribution not identified","Consequences for cell survival not directly tested here"]},{"year":2012,"claim":"Defined mitochondrial HK2 as a glucose-sensing molecular switch governing cell fate and showed hypoxic recruitment of TIGAR potentiates its activity to limit ROS.","evidence":"Co-IP, subcellular fractionation, ROS and cell death assays under hypoxia and glucose deprivation","pmids":["22233811","23185017"],"confidence":"High","gaps":["Structural basis of the HK2-PEA15 and HK2-TIGAR interactions unresolved","Quantitative thresholds for switch behavior undefined"]},{"year":2002,"claim":"Identified AMPK and calcium/calcineurin-CaMK signaling as upstream transcriptional regulators linking metabolic and contractile signals to HKII expression in muscle.","evidence":"AICAR infusion in rats and pharmacological calcineurin/CaMK inhibition in skeletal muscle","pmids":["12388122","17516843"],"confidence":"Medium","gaps":["Direct promoter-binding effectors downstream of these kinases not mapped","Generalizability beyond muscle untested"]},{"year":2015,"claim":"Resolved how HK2 abundance is coupled to glucose supply, identifying it as a glucose-regulated chaperone-mediated autophagy substrate whose excessive degradation causes metabolic catastrophe.","evidence":"CMA-substrate proteomics, lysosomal fractionation, and genetic/pharmacological CMA manipulation","pmids":["26323688","26075878"],"confidence":"High","gaps":["Interplay between CMA and proteasomal turnover not quantified","Autophagy-switch mechanism in cardiomyocytes mechanistically thin"]},{"year":2019,"claim":"Mechanistically linked Akt/GSK3β signaling to HK2 mitochondrial release, showing GSK3β-driven VDAC phosphorylation dissociates HK2 to trigger apoptosis.","evidence":"HK2-VDAC Co-IP, phospho-VDAC blots, glycolysis and apoptosis assays with GSK3β activator/AKT inhibitor; p53/zinc context in prostate cancer","pmids":["31669347","30528266"],"confidence":"Medium","gaps":["VDAC phosphosite specificity not fully mapped","Single-lab pharmacological models"]},{"year":2017,"claim":"Expanded the HK2 transcriptional network by showing oncogenic YAP/TEAD-p65 cooperation drives HK2 expression to promote migration, and subsequent studies added repressors and additional activators.","evidence":"Co-IP, ChIP at HK2 promoter, and reporter/migration assays; later ChIP studies of FOXE1, KLF14, ZNF281, Foxp1, PPARγ/PER1, ATF4/HIF-1α, CCT6A/STAT1","pmids":["28945218","31918722","34983946","36514923","39083899","22334075","35255118","37481013","38750462","22233811"],"confidence":"Medium","gaps":["Hierarchy and combinatorial logic among these factors unresolved","Most defined in single cancer/inflammation contexts"]},{"year":2022,"claim":"Established a layer of post-transcriptional and epitranscriptomic control of HK2, with m6A (METTL3), ac4C (NAT10), and nuclear pre-mRNA retention (FTO) tuning HK2 mRNA fate.","evidence":"m6A/ac4C sequencing, nuclear/cytoplasmic fractionation, and ubiquitination assays across cancer models","pmids":["36403721","39990211","36075458"],"confidence":"Medium","gaps":["Relative contribution of each RNA modification not compared","Reader proteins for HK2 mRNA marks not all identified"]},{"year":2022,"claim":"Revealed non-canonical HK2 functions beyond glycolysis: a protein-kinase activity phosphorylating IκBα at Thr291 and nuclear HK2 binding HIF-1α, both converging on NF-κB/HIF-driven PD-L1 to enable immune evasion.","evidence":"Site-directed mutagenesis, phosphorylation and Co-IP assays, PD-L1 reporters, and tumor specimen analysis","pmids":["37377974","37300724"],"confidence":"Medium","gaps":["Structural basis of HK2 protein-kinase activity undefined","Substrate repertoire beyond IκBα unknown"]},{"year":2023,"claim":"Defined competing ubiquitin codes governing HK2 stability and localization—K48 ubiquitination (TRIM36, UBR7-Keap1 axis) drives degradation while CSN5 and K63-specific OTUD1 deubiquitination control abundance and mitochondrial residence.","evidence":"Linkage-specific ubiquitination assays, Co-IP, domain mapping, and in vivo KO models","pmids":["36799474","36419136","31991125","40500776"],"confidence":"Medium","gaps":["Coordination among these E3s/DUBs not integrated","Cell-type specificity of each enzyme pair unclear"]},{"year":2023,"claim":"Identified STING as a direct enzymatic inhibitor of HK2, decoupling glycolytic restriction from innate immune signaling and connecting HK2 activity to antitumor immunity.","evidence":"In vitro hexokinase activity assays, STING manipulation, in vivo tumor models, and human CRC correlation","pmids":["37443289"],"confidence":"High","gaps":["Structural mode of STING-HK2 inhibition undefined","Stoichiometry and reversibility not established"]},{"year":2024,"claim":"Connected HK2-driven glycolysis to chromatin via lactate, showing HK2-generated lactate promotes H3K18 lactylation that feeds back to activate the HK2 promoter, forming a self-amplifying loop.","evidence":"HK2 knockout mice, Seahorse analysis, and ChIP for H3K18 lactylation at the HK2 promoter in renal ischemia-reperfusion","pmids":["39217289"],"confidence":"Medium","gaps":["Single disease context","Direct vs indirect lactylation effects on transcription not dissected"]},{"year":null,"claim":"How HK2's canonical glycolytic, moonlighting protein-kinase, nuclear transcriptional, and mitochondrial death-switch functions are spatially and temporally coordinated within a single cell remains unresolved.","evidence":"No single study integrates these activities under defined physiological transitions","pmids":[],"confidence":"Low","gaps":["No structural model linking localization to non-canonical activities","Quantitative partitioning of HK2 pools (cytosolic/mitochondrial/nuclear) undefined","Causal hierarchy among the regulatory layers not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,4]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[15]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[27]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,6,7,8,18,32]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,11]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,5,6,18]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,12,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,15,18]}],"complexes":[],"partners":["VDAC1","PEA15","TIGAR","OTUD1","STING","CSN5","TRIM36","HIF-1Α"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P52789","full_name":"Hexokinase-2","aliases":["Hexokinase type II","HK II","Hexokinase-B","Muscle form hexokinase"],"length_aa":917,"mass_kda":102.4,"function":"Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively) (PubMed:23185017, PubMed:26985301, PubMed:29298880). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate (PubMed:29298880). Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis (PubMed:18350175)","subcellular_location":"Mitochondrion outer membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P52789/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HK2","classification":"Not Classified","n_dependent_lines":279,"n_total_lines":1208,"dependency_fraction":0.23096026490066227},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"IPO13","stoichiometry":0.2},{"gene":"POLR3E","stoichiometry":0.2},{"gene":"TMA16","stoichiometry":0.2},{"gene":"TOMM20A","stoichiometry":0.2},{"gene":"VDAC1","stoichiometry":0.2},{"gene":"VDAC3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HK2","total_profiled":1310},"omim":[{"mim_id":"621181","title":"NF-KAPPA-B-INTERACTING LONG NONCODING RNA; NKILA","url":"https://www.omim.org/entry/621181"},{"mim_id":"620936","title":"WD REPEAT-CONTAINING PROTEIN 27; WDR27","url":"https://www.omim.org/entry/620936"},{"mim_id":"620935","title":"TESTIS-EXPRESSED GENE 9; TEX9","url":"https://www.omim.org/entry/620935"},{"mim_id":"620701","title":"TETRATRICOPEPTIDE REPEAT DOMAIN 36; TTC36","url":"https://www.omim.org/entry/620701"},{"mim_id":"618802","title":"tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN; THG1L","url":"https://www.omim.org/entry/618802"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"retina","ntpm":133.5}],"url":"https://www.proteinatlas.org/search/HK2"},"hgnc":{"alias_symbol":["HKII"],"prev_symbol":[]},"alphafold":{"accession":"P52789","domains":[{"cath_id":"3.40.367.20","chopping":"2-59_269-445","consensus_level":"high","plddt":93.2475,"start":2,"end":445},{"cath_id":"3.30.420.40","chopping":"65-208_448-461","consensus_level":"high","plddt":89.617,"start":65,"end":461},{"cath_id":"3.40.367.20","chopping":"715-888","consensus_level":"medium","plddt":93.786,"start":715,"end":888}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P52789","model_url":"https://alphafold.ebi.ac.uk/files/AF-P52789-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P52789-F1-predicted_aligned_error_v6.png","plddt_mean":92.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HK2","jax_strain_url":"https://www.jax.org/strain/search?query=HK2"},"sequence":{"accession":"P52789","fasta_url":"https://rest.uniprot.org/uniprotkb/P52789.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P52789/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P52789"}},"corpus_meta":[{"pmid":"9759557","id":"PMC_9759557","title":"Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.","date":"1998","source":"Critical reviews in clinical laboratory sciences","url":"https://pubmed.ncbi.nlm.nih.gov/9759557","citation_count":267,"is_preprint":false},{"pmid":"26075878","id":"PMC_26075878","title":"HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection.","date":"2015","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26075878","citation_count":234,"is_preprint":false},{"pmid":"23185017","id":"PMC_23185017","title":"Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23185017","citation_count":197,"is_preprint":false},{"pmid":"30543165","id":"PMC_30543165","title":"Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.","date":"2019","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30543165","citation_count":170,"is_preprint":false},{"pmid":"28602700","id":"PMC_28602700","title":"Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28602700","citation_count":138,"is_preprint":false},{"pmid":"22334075","id":"PMC_22334075","title":"PPARγ contributes to PKM2 and HK2 expression in fatty liver.","date":"2012","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/22334075","citation_count":132,"is_preprint":false},{"pmid":"37443289","id":"PMC_37443289","title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.","date":"2023","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37443289","citation_count":125,"is_preprint":false},{"pmid":"26323688","id":"PMC_26323688","title":"Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26323688","citation_count":110,"is_preprint":false},{"pmid":"34983946","id":"PMC_34983946","title":"The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis.","date":"2022","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34983946","citation_count":105,"is_preprint":false},{"pmid":"15627654","id":"PMC_15627654","title":"Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues.","date":"2005","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15627654","citation_count":100,"is_preprint":false},{"pmid":"34200774","id":"PMC_34200774","title":"Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34200774","citation_count":99,"is_preprint":false},{"pmid":"26884725","id":"PMC_26884725","title":"Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth.","date":"2016","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/26884725","citation_count":93,"is_preprint":false},{"pmid":"12388122","id":"PMC_12388122","title":"AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle.","date":"2002","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12388122","citation_count":84,"is_preprint":false},{"pmid":"35255118","id":"PMC_35255118","title":"Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer.","date":"2022","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35255118","citation_count":83,"is_preprint":false},{"pmid":"28488541","id":"PMC_28488541","title":"MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28488541","citation_count":80,"is_preprint":false},{"pmid":"35226829","id":"PMC_35226829","title":"Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4).","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35226829","citation_count":75,"is_preprint":false},{"pmid":"36419136","id":"PMC_36419136","title":"UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36419136","citation_count":72,"is_preprint":false},{"pmid":"28945218","id":"PMC_28945218","title":"TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration.","date":"2017","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28945218","citation_count":72,"is_preprint":false},{"pmid":"36042519","id":"PMC_36042519","title":"HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways.","date":"2022","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/36042519","citation_count":70,"is_preprint":false},{"pmid":"30322879","id":"PMC_30322879","title":"Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30322879","citation_count":70,"is_preprint":false},{"pmid":"34741026","id":"PMC_34741026","title":"Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34741026","citation_count":65,"is_preprint":false},{"pmid":"22233811","id":"PMC_22233811","title":"Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22233811","citation_count":62,"is_preprint":false},{"pmid":"28596599","id":"PMC_28596599","title":"The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28596599","citation_count":56,"is_preprint":false},{"pmid":"38889331","id":"PMC_38889331","title":"Cordycepin Modulates Microglial M2 Polarization Coupled with Mitochondrial Metabolic Reprogramming by Targeting HKII and PDK2.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38889331","citation_count":55,"is_preprint":false},{"pmid":"36403721","id":"PMC_36403721","title":"Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36403721","citation_count":55,"is_preprint":false},{"pmid":"37481013","id":"PMC_37481013","title":"ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.","date":"2023","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/37481013","citation_count":55,"is_preprint":false},{"pmid":"19228992","id":"PMC_19228992","title":"Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion.","date":"2009","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/19228992","citation_count":51,"is_preprint":false},{"pmid":"30885978","id":"PMC_30885978","title":"An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1-HK2+ Multiple Myeloma.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30885978","citation_count":49,"is_preprint":false},{"pmid":"31669347","id":"PMC_31669347","title":"Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII.","date":"2019","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31669347","citation_count":47,"is_preprint":false},{"pmid":"37506502","id":"PMC_37506502","title":"TRPV4-mediated mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via the Drp1-HK2 axis.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37506502","citation_count":45,"is_preprint":false},{"pmid":"37377974","id":"PMC_37377974","title":"Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37377974","citation_count":44,"is_preprint":false},{"pmid":"34110962","id":"PMC_34110962","title":"MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.","date":"2021","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/34110962","citation_count":44,"is_preprint":false},{"pmid":"37300724","id":"PMC_37300724","title":"Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression.","date":"2023","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/37300724","citation_count":41,"is_preprint":false},{"pmid":"37179292","id":"PMC_37179292","title":"The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37179292","citation_count":40,"is_preprint":false},{"pmid":"31530094","id":"PMC_31530094","title":"The Roles of HK2 on Tumorigenesis of Cervical Cancer.","date":"2019","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/31530094","citation_count":40,"is_preprint":false},{"pmid":"30980888","id":"PMC_30980888","title":"Novel xanthine oxidase-based cell model using HK-2 cell for screening antihyperuricemic functional compounds.","date":"2019","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30980888","citation_count":40,"is_preprint":false},{"pmid":"31991125","id":"PMC_31991125","title":"CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31991125","citation_count":39,"is_preprint":false},{"pmid":"35719058","id":"PMC_35719058","title":"Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35719058","citation_count":38,"is_preprint":false},{"pmid":"35863742","id":"PMC_35863742","title":"Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.","date":"2022","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35863742","citation_count":36,"is_preprint":false},{"pmid":"36335239","id":"PMC_36335239","title":"A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36335239","citation_count":36,"is_preprint":false},{"pmid":"27260001","id":"PMC_27260001","title":"Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27260001","citation_count":36,"is_preprint":false},{"pmid":"31742425","id":"PMC_31742425","title":"PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.","date":"2019","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/31742425","citation_count":34,"is_preprint":false},{"pmid":"12595498","id":"PMC_12595498","title":"TGF-beta1-mediated inhibition of HK-2 cell migration.","date":"2003","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/12595498","citation_count":34,"is_preprint":false},{"pmid":"33536762","id":"PMC_33536762","title":"CPNE1 Enhances Colorectal Cancer Cell Growth, Glycolysis, and Drug Resistance Through Regulating the AKT-GLUT1/HK2 Pathway.","date":"2021","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33536762","citation_count":32,"is_preprint":false},{"pmid":"36799474","id":"PMC_36799474","title":"Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/36799474","citation_count":32,"is_preprint":false},{"pmid":"30528266","id":"PMC_30528266","title":"Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30528266","citation_count":30,"is_preprint":false},{"pmid":"17516843","id":"PMC_17516843","title":"Calcium signalling in the regulation of PGC-1alpha, PDK4 and HKII mRNA expression.","date":"2007","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17516843","citation_count":29,"is_preprint":false},{"pmid":"31918722","id":"PMC_31918722","title":"FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/31918722","citation_count":29,"is_preprint":false},{"pmid":"38750462","id":"PMC_38750462","title":"CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38750462","citation_count":29,"is_preprint":false},{"pmid":"35328104","id":"PMC_35328104","title":"Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328104","citation_count":29,"is_preprint":false},{"pmid":"33488124","id":"PMC_33488124","title":"NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33488124","citation_count":28,"is_preprint":false},{"pmid":"32495363","id":"PMC_32495363","title":"FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32495363","citation_count":28,"is_preprint":false},{"pmid":"36514923","id":"PMC_36514923","title":"ZNF281 drives hepatocyte senescence in alcoholic liver disease by reducing HK2-stabilized PINK1/Parkin-mediated mitophagy.","date":"2022","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/36514923","citation_count":28,"is_preprint":false},{"pmid":"32104945","id":"PMC_32104945","title":"CircPRKCI relieves lipopolysaccharide-induced HK2 cell injury by upregulating the expression of miR-545 target gene ZEB2.","date":"2020","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32104945","citation_count":28,"is_preprint":false},{"pmid":"26680227","id":"PMC_26680227","title":"XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression.","date":"2015","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26680227","citation_count":28,"is_preprint":false},{"pmid":"32410389","id":"PMC_32410389","title":"Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32410389","citation_count":28,"is_preprint":false},{"pmid":"32964288","id":"PMC_32964288","title":"LncRNA ZFAS1/miR-1271-5p/HK2 Promotes Glioma Development Through Regulating Proliferation, Migration, Invasion and Apoptosis.","date":"2020","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/32964288","citation_count":28,"is_preprint":false},{"pmid":"39217289","id":"PMC_39217289","title":"AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated glycolysis.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/39217289","citation_count":25,"is_preprint":false},{"pmid":"39142439","id":"PMC_39142439","title":"Impaired microglial glycolysis promotes inflammatory responses after intracerebral haemorrhage via HK2-dependent mitochondrial dysfunction.","date":"2024","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/39142439","citation_count":24,"is_preprint":false},{"pmid":"35068445","id":"PMC_35068445","title":"Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma.","date":"2022","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35068445","citation_count":24,"is_preprint":false},{"pmid":"34791822","id":"PMC_34791822","title":"AKT1/HK2 Axis-mediated Glucose Metabolism: A Novel Therapeutic Target of Sulforaphane in Bladder Cancer.","date":"2021","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/34791822","citation_count":23,"is_preprint":false},{"pmid":"34382305","id":"PMC_34382305","title":"Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/34382305","citation_count":23,"is_preprint":false},{"pmid":"33309838","id":"PMC_33309838","title":"Hsa_circ_0069094 accelerates cell malignancy and glycolysis through regulating the miR-591/HK2 axis in breast cancer.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/33309838","citation_count":22,"is_preprint":false},{"pmid":"36752127","id":"PMC_36752127","title":"ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT/β-catenin/HK2 axis.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36752127","citation_count":22,"is_preprint":false},{"pmid":"33253711","id":"PMC_33253711","title":"FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33253711","citation_count":21,"is_preprint":false},{"pmid":"30891546","id":"PMC_30891546","title":"Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice.","date":"2018","source":"Animal models and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30891546","citation_count":20,"is_preprint":false},{"pmid":"36075458","id":"PMC_36075458","title":"E6E7 regulates the HK2 expression in cervical cancer via GSK3β/FTO signal.","date":"2022","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/36075458","citation_count":20,"is_preprint":false},{"pmid":"35167417","id":"PMC_35167417","title":"CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.","date":"2022","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/35167417","citation_count":20,"is_preprint":false},{"pmid":"35914373","id":"PMC_35914373","title":"miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.","date":"2022","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/35914373","citation_count":20,"is_preprint":false},{"pmid":"32733938","id":"PMC_32733938","title":"Circular RNA circFAT1(e2) Promotes Osteosarcoma Progression and Metastasis by Sponging miR-181b and Regulating HK2 Expression.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/32733938","citation_count":20,"is_preprint":false},{"pmid":"31149033","id":"PMC_31149033","title":"Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31149033","citation_count":20,"is_preprint":false},{"pmid":"33500659","id":"PMC_33500659","title":"ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33500659","citation_count":19,"is_preprint":false},{"pmid":"35037827","id":"PMC_35037827","title":"Exosomes derived from calcium oxalate-treated macrophages promote apoptosis of HK-2 cells by promoting autophagy.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35037827","citation_count":19,"is_preprint":false},{"pmid":"34480980","id":"PMC_34480980","title":"Leptin promotes glycolytic metabolism to induce dendritic cells activation via STAT3-HK2 pathway.","date":"2021","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34480980","citation_count":18,"is_preprint":false},{"pmid":"40500776","id":"PMC_40500776","title":"OTUD1 exacerbates sepsis-associated encephalopathy by promoting HK2 mitochondrial release to drive microglia pyroptosis.","date":"2025","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/40500776","citation_count":17,"is_preprint":false},{"pmid":"37909251","id":"PMC_37909251","title":"HK2 in microglia and macrophages contribute to the development of neuropathic pain.","date":"2023","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/37909251","citation_count":17,"is_preprint":false},{"pmid":"34220956","id":"PMC_34220956","title":"Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34220956","citation_count":17,"is_preprint":false},{"pmid":"37529037","id":"PMC_37529037","title":"Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37529037","citation_count":16,"is_preprint":false},{"pmid":"30871777","id":"PMC_30871777","title":"Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30871777","citation_count":15,"is_preprint":false},{"pmid":"36431990","id":"PMC_36431990","title":"Angelica sinensis Polysaccharide and Astragalus membranaceus Polysaccharide Accelerate Liver Regeneration by Enhanced Glycolysis via Activation of JAK2/STAT3/HK2 Pathway.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36431990","citation_count":15,"is_preprint":false},{"pmid":"39083899","id":"PMC_39083899","title":"Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39083899","citation_count":14,"is_preprint":false},{"pmid":"37079118","id":"PMC_37079118","title":"ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.","date":"2023","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37079118","citation_count":14,"is_preprint":false},{"pmid":"39991762","id":"PMC_39991762","title":"The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products.","date":"2025","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39991762","citation_count":14,"is_preprint":false},{"pmid":"32726127","id":"PMC_32726127","title":"MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells.","date":"2020","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/32726127","citation_count":14,"is_preprint":false},{"pmid":"34576046","id":"PMC_34576046","title":"Renal Ischemia/Reperfusion Early Induces Myostatin and PCSK9 Expression in Rat Kidneys and HK-2 Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34576046","citation_count":14,"is_preprint":false},{"pmid":"34664737","id":"PMC_34664737","title":"Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2.","date":"2021","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/34664737","citation_count":13,"is_preprint":false},{"pmid":"39990211","id":"PMC_39990211","title":"Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis.","date":"2025","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/39990211","citation_count":12,"is_preprint":false},{"pmid":"35958341","id":"PMC_35958341","title":"BARX2/FOXA1/HK2 axis promotes lung adenocarcinoma progression and energy metabolism reprogramming.","date":"2022","source":"Translational lung cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35958341","citation_count":12,"is_preprint":false},{"pmid":"36278443","id":"PMC_36278443","title":"Advances in the Study of Hexokinase 2 (HK2) Inhibitors.","date":"2023","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36278443","citation_count":12,"is_preprint":false},{"pmid":"31186081","id":"PMC_31186081","title":"ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.","date":"2019","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/31186081","citation_count":12,"is_preprint":false},{"pmid":"31163002","id":"PMC_31163002","title":"Niban protein regulates apoptosis in HK-2 cells via caspase-dependent pathway.","date":"2019","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/31163002","citation_count":12,"is_preprint":false},{"pmid":"8950360","id":"PMC_8950360","title":"Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.","date":"1996","source":"The Prostate. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/8950360","citation_count":12,"is_preprint":false},{"pmid":"36778593","id":"PMC_36778593","title":"Effect of transferrin glycation induced by high glucose on HK-2 cells in vitro.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36778593","citation_count":12,"is_preprint":false},{"pmid":"32791339","id":"PMC_32791339","title":"CaMKII as a key regulator of contrast-induced nephropathy through mPTP opening in HK-2 cells.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/32791339","citation_count":12,"is_preprint":false},{"pmid":"39505995","id":"PMC_39505995","title":"FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39505995","citation_count":11,"is_preprint":false},{"pmid":"33627057","id":"PMC_33627057","title":"hsa-miR-9-5p Down-Regulates HK2 and Confers Radiosensitivity to Nasopharyngeal Carcinoma.","date":"2021","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33627057","citation_count":11,"is_preprint":false},{"pmid":"39054546","id":"PMC_39054546","title":"Cancer-associated fibroblast-derived WNT5A promotes cell proliferation, metastasis, stemness and glycolysis in gastric cancer via regulating HK2.","date":"2024","source":"World journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39054546","citation_count":11,"is_preprint":false},{"pmid":"24768635","id":"PMC_24768635","title":"ATF3 attenuates cyclosporin A-induced nephrotoxicity by downregulating CHOP in HK-2 cells.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24768635","citation_count":11,"is_preprint":false},{"pmid":"38686047","id":"PMC_38686047","title":"Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway.","date":"2024","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/38686047","citation_count":10,"is_preprint":false},{"pmid":"32560813","id":"PMC_32560813","title":"Gomisin J inhibits the glioma progression by inducing apoptosis and reducing HKII-regulated glycolysis.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32560813","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53507,"output_tokens":8912,"usd":0.1471,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18876,"output_tokens":4680,"usd":0.10569,"stage2_stop_reason":"end_turn"},"total_usd":0.25279,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Under hypoxia, TIGAR protein relocalizes to mitochondria and forms a direct complex with HK2, resulting in an increase in HK2 hexokinase activity. Mitochondrial localization of TIGAR depends on mitochondrial HK2 and HIF1α activity. TIGAR's fructose-2,6-bisphosphatase activity is independent of HK2 binding, but both activities contribute to limiting mitochondrial ROS and protecting from cell death.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, mitochondrial localization assays, ROS measurement, cell death assays in hypoxic cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with functional consequence (HK2 activity increase), subcellular fractionation, multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"23185017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mitochondrial HK2 interacts directly with PEA15 (phosphoprotein enriched in astrocytes) to form a molecular switch governing cell fate: HK2 + PEA15 inhibits apoptosis after hypoxia, whereas HK2 without PEA15 under glucose deprivation accelerates apoptosis. HK2 thus functions both as a cytoprotective molecule and as a glucose availability sensor that triggers apoptosis under metabolic stress.\",\n      \"method\": \"Co-immunoprecipitation, genetic overexpression/knockdown, cell death assays under hypoxia and glucose deprivation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying direct interactor, multiple functional readouts (apoptosis induction/inhibition), two orthogonal experimental conditions in one study\",\n      \"pmids\": [\"22233811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HK2 is degraded by chaperone-mediated autophagy (CMA) and is a bona fide CMA substrate. HK2 degradation by CMA is regulated by glucose availability (reduced glucose increases CMA-mediated HK2 degradation). Excessive CMA activation, triggered by perturbation of FLT3 signaling, leads to HK2 degradation, metabolic catastrophe, and cancer cell death.\",\n      \"method\": \"Proteome analysis identifying CMA substrates, lysosomal fraction assays, genetic manipulation of CMA pathway components, glucose availability modulation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics-based substrate identification with functional validation using multiple genetic and pharmacological approaches in a single rigorous study\",\n      \"pmids\": [\"26323688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HK2 facilitates autophagy in response to glucose deprivation (substrate deprivation) to protect cardiomyocytes, functioning as a molecular switch from glycolysis to autophagy to ensure cellular energy homeostasis under starvation conditions.\",\n      \"method\": \"Glucose deprivation experiments in cardiomyocytes, autophagy flux assays, HK2 overexpression/knockdown with cellular survival readouts\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined cellular role with specific phenotypic readout (autophagy induction), single lab, limited mechanistic detail in abstract\",\n      \"pmids\": [\"26075878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"STING directly targets HK2 to block its hexokinase enzymatic activity, thereby restricting aerobic glycolysis independent of STING's innate immune signaling function. STING inhibition of HK2 promotes antitumor immunity in vivo.\",\n      \"method\": \"In vitro hexokinase activity assays, genetic manipulation of STING expression, in vivo tumor models, correlative analysis in human colorectal carcinoma samples\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — enzymatic activity assay directly demonstrating STING blocks HK2 hexokinase activity, complemented by in vivo validation, published in high-tier journal\",\n      \"pmids\": [\"37443289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"After mitochondrial translocation under hypoxia, Drp1 promotes excessive mPTP opening through a pathway involving HK2: LRRK2 is recruited and its kinase activity is inhibited by mitochondrial Drp1, causing HK2 inactivation at Thr-473 and its dissociation from the mitochondrial membrane, which disrupts mPTP structure and causes mPTP overopening.\",\n      \"method\": \"Colocalization assays, co-immunoprecipitation, phosphorylation site identification (Thr-473), mitochondrial fractionation, mPTP opening assays in hypoxic cells\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, phosphorylation site mapping, and functional mPTP assays in a single study; single lab\",\n      \"pmids\": [\"34741026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GSK-3β-mediated phosphorylation of mitochondrial VDAC induces dissociation of HK2 from VDAC/mitochondria, leading to glycolytic inhibition and mitochondrial-mediated apoptosis. The flavonoid GL-V9 triggers this mechanism by activating GSK-3β and inhibiting AKT.\",\n      \"method\": \"Co-immunoprecipitation of HK2-VDAC complex, Western blot for phospho-VDAC, glycolysis assays, apoptosis assays, in vivo xenograft\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating HK2-VDAC interaction, phosphorylation mechanism, multiple functional readouts; single lab\",\n      \"pmids\": [\"31669347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Zinc and p53 disrupt mitochondrial binding of HK2 in prostate cancer cells by promoting phosphorylation of VDAC1, mediated through Akt inhibition and GSK3β activation, leading to HK2 mitochondrial dissociation.\",\n      \"method\": \"Subcellular fractionation, Western blot for phospho-VDAC1, co-immunoprecipitation, Akt inhibition and GSK3β activation assays, xenograft model\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway defined with phosphorylation evidence and subcellular localization readout; single lab, multiple methods\",\n      \"pmids\": [\"30528266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ischemic preconditioning (IPC) causes cellular redistribution of HKII (but not HKI): decreased cytosolic HKII during ischemia and increased mitochondrial HKII activity before ischemia and during reperfusion. IPC-mediated decreased cytosolic HK activity during ischemia is explained by decreased HKII protein content in the cytosolic fraction.\",\n      \"method\": \"Subcellular fractionation (mitochondrial, cytosolic, microsomal fractions), hexokinase activity assays, Western blot for HKII protein content in isolated Langendorff-perfused rat hearts\",\n      \"journal\": \"Journal of applied physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular fractionation with activity assays across multiple time points; single lab, rigorous experimental design\",\n      \"pmids\": [\"19228992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TNFα triggers IKK-mediated YAP phosphorylation and activation in breast cancer cells. YAP and p65 interact physically, and the YAP/TEAD and p65 complex synergistically regulates HK2 transcription to promote TNFα-induced cell migration.\",\n      \"method\": \"Co-immunoprecipitation of YAP and p65, chromatin immunoprecipitation (ChIP) showing YAP/TEAD and p65 binding to HK2 promoter, migration assays, reporter assays\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP establishing transcriptional mechanism at HK2 promoter; single lab with two orthogonal methods\",\n      \"pmids\": [\"28945218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KLF14 transcriptionally inhibits HK2 expression in macrophages. KLF14 deletion leads to increased glycolysis (via HK2 upregulation) and increased inflammatory cytokine secretion. Pharmacological KLF14 activation reduces HK2 expression, decreases glycolysis, and confers protection against sepsis.\",\n      \"method\": \"KLF14 knockout mice, siRNA knockdown, promoter assays, cytokine measurement, glycolysis assays, in vivo endotoxemia/sepsis models\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in vivo model combined with in vitro transcriptional mechanism; single lab, multiple methods\",\n      \"pmids\": [\"34983946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SREBP-1 binds to the HK2 (HKII) promoter in vivo in liver, adipose tissue, and skeletal muscle (demonstrated by chromatin immunoprecipitation), and regulates HKII expression in response to nutritional status (fasting/refeeding). SREBP-1 thus plays a major role in nutritional regulation of glucose metabolism via HKII.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) in rat tissues, mRNA and protein expression analysis during fasting/refeeding\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo ChIP demonstrating direct SREBP-1 binding to HKII promoter in multiple tissues; single lab\",\n      \"pmids\": [\"15627654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PPARγ transcription factor binds directly to the HK2 (hexokinase 2) promoter to activate HK2 transcription in PTEN-null fatty liver. HK2 expression, along with PKM2, is under control of Akt2 kinase through PPARγ in this context.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) demonstrating PPARγ binding to HK2 promoter, genetic models (PTEN-null liver, Akt2 knockout), transcriptional reporter assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP evidence for PPARγ at HK2 promoter in vivo with genetic validation; single lab\",\n      \"pmids\": [\"22334075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"AMPK signaling activates transcription of the HKII gene in rat skeletal muscle. Single-leg AICAR infusion (activating AMPK-α2) induced a dose-dependent 2–4-fold increase in HKII transcription specifically in muscle of the infused leg, establishing AMPK as a transcriptional regulator of HKII.\",\n      \"method\": \"Single-leg arterial infusion of AICAR in conscious rats, AMPK activity assays, HKII mRNA quantification in red and white skeletal muscle\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with dose-response, tissue-specific effect confirming AMPK-HKII transcriptional link; single lab\",\n      \"pmids\": [\"12388122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Calcium signaling via calcineurin and CaMK pathways regulates HKII mRNA expression in skeletal muscle. Ionomycin treatment increased HKII mRNA ~2-fold; cyclosporin A (calcineurin inhibitor) and KN-62 (CaMK inhibitor) reduced ionomycin-induced HKII transcription, establishing calcineurin and CaMK as upstream regulators of HKII.\",\n      \"method\": \"Pharmacological inhibition (cyclosporin A, KN-62), ionomycin stimulation, electrical stimulation of isolated muscle, mRNA quantification in primary rat skeletal muscle cells and EDL muscle\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological inhibitors used in both cell culture and ex vivo muscle; single lab, consistent results across two experimental systems\",\n      \"pmids\": [\"17516843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HK2 acts as a protein kinase (non-canonical activity) and phosphorylates IκBα at Thr291 under high glucose conditions in breast cancer cells, leading to rapid IκBα degradation, NF-κB activation, and transcriptional upregulation of PD-L1, thereby promoting immune evasion.\",\n      \"method\": \"Phosphorylation assays, mutagenesis of IκBα Thr291, Co-IP, NF-κB reporter assays, PD-L1 expression analysis, immunohistochemistry in human breast cancer specimens\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific phosphorylation identified with mutagenesis and functional consequence (NF-κB/PD-L1); single lab, multiple methods\",\n      \"pmids\": [\"37377974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CSN5 (COP9 signalosome subunit 5) stabilizes HK2 protein through its deubiquitinase function, attenuating ubiquitin-proteasome-mediated HK2 degradation. CSN5 knockdown decreases HK2 protein level and glycolytic flux; re-expression of HK2 rescues glycolysis. Curcumin inhibition of CSN5 kinase activity decreases HK2 expression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, glycolysis flux measurements, HK2 rescue experiments, in vivo tumor models\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deubiquitination mechanism established with Co-IP and ubiquitination assays plus functional rescue; single lab\",\n      \"pmids\": [\"31991125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TRIM36 E3 ubiquitin ligase directly binds HK2 and promotes its degradation via K48-linked ubiquitination. TRIM36-mediated HK2 ubiquitination reduces HK2 protein, suppresses glycolysis, decreases GPx4 expression, and activates ferroptosis to inhibit neuroendocrine differentiation in prostate cancer.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays specifying K48-linkage, proteomic analysis, ferroptosis assays, HK2 knockdown/overexpression\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — linkage-specific ubiquitination identified with Co-IP and functional downstream consequence; single lab\",\n      \"pmids\": [\"36799474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OTUD1 deubiquitinase directly binds to the C-terminal domain of HK2 via its Ala-rich domain and selectively cleaves K63-linked polyubiquitin chains on HK2, promoting HK2 dissociation from mitochondria. Mitochondrial HK2 dissociation activates the NLRP3 inflammasome and pyroptosis in microglia, causing neuroinflammation in sepsis-associated encephalopathy.\",\n      \"method\": \"Molecular docking, co-immunoprecipitation, 3D confocal microscopy, OTUD1 knockout mice, primary microglia experiments, behavioral tests, Western blot for K63-ubiquitin linkage\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — linkage-specific deubiquitination with domain mapping and in vivo KO validation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"40500776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HK2 undergoes circadian oscillation in trastuzumab-resistant gastric cancer cells, regulated by a transcriptional complex composed of PPARγ and the core clock gene PER1. Higher HK2-dependent glycolysis at ZT6 and lower at ZT18 is controlled by the BMAL1-CLOCK-PER1-HK2 axis. Silencing PER1 disrupts HK2 circadian rhythm and reverses trastuzumab resistance.\",\n      \"method\": \"In vivo and in vitro circadian glycolysis assays, PER1 silencing, ChIP for transcriptional complex at HK2 promoter, trastuzumab resistance models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating PPARγ/PER1 complex at HK2 promoter, with circadian functional readout in vivo and in vitro; single lab\",\n      \"pmids\": [\"35255118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UBR7 E3 ligase monoubiquitinates histone H2B at K120 (H2BK120ub), which regulates Keap1 promoter binding, thereby controlling Keap1 expression and downstream Nrf2/Bach1/HK2 signaling. UBR7 loss de-represses HK2 expression to promote aerobic glycolysis and HCC tumorigenesis.\",\n      \"method\": \"RNAi screening, ChIP showing H2BK120ub at Keap1 promoter, Western blot, glycolysis assays, in vivo tumor models\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-validated epigenetic mechanism linking UBR7 to HK2 through Keap1/Nrf2/Bach1 axis; single lab\",\n      \"pmids\": [\"36419136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FOXE1 transcription factor directly binds to the HK2 promoter and negatively regulates HK2 transcription, thereby suppressing aerobic glycolysis in colorectal cancer cells.\",\n      \"method\": \"ChIP assay demonstrating FOXE1 binding to HK2 promoter, luciferase reporter assays, gene knockdown/overexpression, glycolysis assays\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP evidence for FOXE1 at HK2 promoter with functional transcriptional consequence; single lab\",\n      \"pmids\": [\"31918722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CCT6A interacts with STAT1 protein via co-immunoprecipitation, forming a complex that enhances STAT1 stability by protecting it from ubiquitin-mediated degradation. Stabilized STAT1 then facilitates transcription of HK2, stimulating aerobic glycolysis in lung adenocarcinoma.\",\n      \"method\": \"Co-immunoprecipitation, ChIP assay, transcriptomic sequencing, LC-MS/MS, gene silencing with phenotypic readouts\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP establishing CCT6A/STAT1/HK2 transcriptional axis; single lab with two orthogonal methods\",\n      \"pmids\": [\"38750462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ATF4 directly binds to the HK2 promoter region and interacts with HIF-1α, stabilizing HIF-1α through ubiquitination modification in response to LPS. The ATF4-HIF-1α-HK2-glycolysis axis activates pro-inflammatory macrophage response via mTOR.\",\n      \"method\": \"Promoter binding assays, co-immunoprecipitation of ATF4-HIF-1α, ubiquitination assays, glycolysis measurements, cytokine assays, Atf4 knockdown/overexpression\",\n      \"journal\": \"Clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter binding plus Co-IP establishing the ATF4-HIF-1α-HK2 axis; single lab\",\n      \"pmids\": [\"37481013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Glutamate from nerve cells activates NMDAR on pancreatic cancer cells, causing Ca2+ influx and CaMKII/ERK-MAPK pathway activation, which promotes METTL3 transcription. METTL3 then upregulates HK2 expression through N6-methyladenosine (m6A) modification of HK2 mRNA, enhancing glycolysis and perineural invasion.\",\n      \"method\": \"Ca2+ influx assays, pathway inhibition, METTL3 knockdown/overexpression, m6A sequencing/modification assays, HK2 expression analysis, in vivo sciatic nerve invasion model\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — m6A modification of HK2 mRNA established with sequencing; mechanistic pathway defined with multiple pharmacological inhibitors; single lab\",\n      \"pmids\": [\"36403721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NAT10 RNA acetyltransferase stimulates ac4C modification at the junction of the CDS and 3'UTR of HK2 mRNA, enhancing HK2 mRNA stability and protein expression to activate glycolysis and drive gastric tumorigenesis. Glucose deprivation activates autophagy-lysosome degradation of NAT10, reducing ac4C modification of HK2.\",\n      \"method\": \"Dot blotting, immunofluorescence, co-immunoprecipitation, high-throughput sequencing (ac4C-seq), conditional knockout mouse model, organoids, GC xenografts, PET/CT imaging\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — epitranscriptomic modification (ac4C) of HK2 mRNA established with sequencing plus multiple orthogonal methods and in vivo validation including CKO mouse and organoids\",\n      \"pmids\": [\"39990211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"E6E7 HPV oncogenes activate GSK3β transcription in cervical cancer cells; GSK3β promotes ubiquitination-proteasomal degradation of FTO; reduced FTO retains HK2 pre-mRNA in the nucleus, preventing maturation to cytoplasmic HK2 mRNA, thereby upregulating HK2 protein expression.\",\n      \"method\": \"qRT-PCR for pre-mRNA vs. mature mRNA, Western blot, nuclear/cytoplasmic fractionation, overexpression of E6E7 and FTO, ubiquitination assays\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pre-mRNA nuclear retention mechanism supported by subcellular fractionation and multiple molecular tools; single lab\",\n      \"pmids\": [\"36075458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HK2 translocates to the nucleus in gastric cancer cells under GCMSC-derived IL-8 stimulation via AKT-mediated phosphorylation. Phosphorylated nuclear HK2 promotes PD-L1 transcription by binding to HIF-1α.\",\n      \"method\": \"Subcellular fractionation, Western blot, co-immunoprecipitation of HK2 and HIF-1α, AKT inhibition experiments, PD-L1 reporter assays\",\n      \"journal\": \"Gastric cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear localization with functional consequence (PD-L1 transcription) established via fractionation and Co-IP; single lab\",\n      \"pmids\": [\"37300724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ZNF281 directly binds to the 5'-GGCGGCGGGCGG-3' motif within the HK2 promoter and transcriptionally represses HK2 expression, reducing HK2-PINK1/Parkin signaling-mediated mitophagy and promoting hepatocyte senescence in alcoholic liver disease.\",\n      \"method\": \"ChIP assay, promoter binding assays identifying specific binding motif, siRNA knockdown, adeno-associated virus ZNF281 shRNA in vivo, mitophagy assays\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with specific motif identification and in vivo validation; single lab, functional mitophagy readout\",\n      \"pmids\": [\"36514923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In renal ischemia-reperfusion injury, HK2-mediated glycolysis generates lactate that promotes H3K18 lactylation, which in turn is enriched at the HK2 promoter (ChIP) and upregulates HK2 expression, forming a positive feedback loop. AST-120 breaks this loop by suppressing HK2.\",\n      \"method\": \"HK2 knockout mice, Seahorse analysis, chromatin immunoprecipitation for H3K18 lactylation at HK2 promoter, Western blotting, H/R cell model\",\n      \"journal\": \"Molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating histone lactylation at HK2 promoter with HK2 KO validation; single lab\",\n      \"pmids\": [\"39217289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In endothelial cells, Foxp1 transcriptionally represses Hif1α, which in turn represses Hk2 transcription. Foxp1 deletion in ECs increases Hif1α→Hk2 expression, hyperglycolysis, and tumor angiogenesis. Genetic deletion of EC-Hif1α or siRNA knockdown of Hif1α/Hk2 delivered via RGD-peptide nanoparticles reduces tumor EC hyperglycolysis and restricts angiogenesis.\",\n      \"method\": \"EC-specific Foxp1/Hif1α knockout mice, nanoparticle-mediated siRNA delivery, angiogenesis assays, retinal and tumor vascularization studies, TCGA analysis\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo establishing Foxp1-Hif1α-Hk2 pathway in ECs with functional angiogenesis readout; single lab\",\n      \"pmids\": [\"39083899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dhcr24 overexpression activates the PI3K/Akt/HKII pathway in cardiomyocytes, leading to reduced Bax translocation and inhibition of mitochondrial-dependent apoptosis. Knockdown of Dhcr24 reduces PI3K/Akt/HKII pathway activation. HKII inhibition partially reverses the anti-apoptotic effect of Dhcr24 in H9c2 cells.\",\n      \"method\": \"Transgenic overexpression, Dhcr24 knockdown, Western blot, TUNEL assay, HKII inhibitor (2-DG) in H9c2 cells, PI3K inhibitor\",\n      \"journal\": \"Animal models and experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic overexpression and inhibitor epistasis placing HKII downstream of Dhcr24/Akt with apoptosis readout; single lab\",\n      \"pmids\": [\"30891546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mitochondria-bound HK2 (requiring intact N-terminal mitochondrial binding motif) regulates the invasive and migratory phenotype of RA fibroblast-like synoviocytes (FLS). Overexpression of full-length HK2 promotes FLS invasion/migration after PDGF stimulation; HK2 lacking its mitochondrial binding motif (HK2ΔN) reverses this. Tofacitinib but not methotrexate promotes HK2 dissociation from mitochondria.\",\n      \"method\": \"Adenoviral overexpression of FL-HK2 vs. HK2ΔN, confocal microscopy for localization, migration/invasion assays, in vivo arthritis model, scRNA-seq data analysis\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain deletion experiment (HK2ΔN) directly linking mitochondrial localization to FLS invasive phenotype; in vivo validation; single lab\",\n      \"pmids\": [\"37529037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TRPV4 calcium channel activation induces Drp1 mitochondrial translocation via Ca2+-CaMKII signaling, which subsequently causes HK2 dissociation from the mitochondrial membrane, leading to mPTP overopening, mitochondrial dysfunction, and chondrocyte pyroptosis in osteoarthritis.\",\n      \"method\": \"Ca2+ measurement, CaMKII signaling assays, Drp1 translocation assays, HK2 mitochondrial fractionation, mPTP opening assays, TRPV4 inhibitor in ACLT mouse model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway defined with multiple signaling assays and in vivo mouse model; single lab\",\n      \"pmids\": [\"37506502\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HK2 (hexokinase II) catalyzes the first committed step of glycolysis (glucose → glucose-6-phosphate) and is regulated transcriptionally by SREBP-1, PPARγ, AMPK, KLF14, FOXE1, and calcium/calcineurin/CaMK pathways; its protein stability is controlled by CMA-mediated lysosomal degradation, COP9 signalosome (CSN5) deubiquitination, TRIM36- and UBR7-mediated K48-linked ubiquitination, and OTUD1-mediated K63-linked deubiquitination; mitochondrial localization (via the N-terminal binding to VDAC) is dynamically regulated by Akt/GSK3β-mediated VDAC phosphorylation and governs both cell survival (via interaction with PEA15 under hypoxia) and apoptosis induction (under glucose deprivation); beyond canonical glycolysis, HK2 exerts non-canonical protein kinase activity (phosphorylating IκBα at Thr291 to activate NF-κB/PD-L1), acts as a molecular switch to induce autophagy during substrate deprivation, and its mitochondrial dissociation (triggered by Drp1, OTUD1, or pharmacological agents) activates the NLRP3 inflammasome and mPTP overopening; STING directly blocks HK2 enzymatic activity to restrict aerobic glycolysis and promote antitumor immunity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HK2 catalyzes the committed, glucose-6-phosphate-generating step of glycolysis and serves as a metabolic hub whose subcellular localization, abundance, and even non-enzymatic activities couple glucose availability to cell fate [#1, #8]. A defining feature is its N-terminal binding to mitochondria via VDAC: this association is dynamically controlled by Akt/GSK3\\u03b2 signaling, where GSK3\\u03b2-mediated VDAC phosphorylation drives HK2 dissociation, glycolytic inhibition, and mitochondrial apoptosis [#6, #7]. At the mitochondrion HK2 forms a molecular switch that determines survival versus death\\u2014partnering with PEA15 to suppress apoptosis after hypoxia while triggering apoptosis under glucose deprivation [#1]\\u2014and its enzymatic activity is potentiated by hypoxia-driven recruitment of TIGAR, which limits mitochondrial ROS [#0]. HK2 dissociation from mitochondria, induced by Drp1/CaMKII signaling or by OTUD1-mediated K63 deubiquitination, disrupts the mitochondrial permeability transition pore and activates the NLRP3 inflammasome and pyroptosis [#5, #18, #33]. HK2 protein abundance is tightly set by competing degradation routes, including chaperone-mediated autophagy responsive to glucose levels [#2], CSN5/OTUD1 deubiquitination [#16, #18], and TRIM36/UBR7-linked ubiquitin-proteasome turnover [#17, #20]. HK2 transcription integrates an extensive regulatory network spanning nutritional and stress signaling (SREBP-1, AMPK, PPAR\\u03b3, calcium/calcineurin-CaMK, ATF4/HIF-1\\u03b1) and repressive factors (KLF14, FOXE1, ZNF281, Foxp1) [#11, #13, #12, #14, #23, #10, #21, #28, #30], and its mRNA is further controlled by epitranscriptomic marks (m6A via METTL3, ac4C via NAT10) and nuclear pre-mRNA retention [#24, #25, #26]. Beyond catalysis, HK2 has non-canonical functions: it acts as a protein kinase phosphorylating I\\u03baB\\u03b1 at Thr291 to activate NF-\\u03baB and induce PD-L1 [#15], translocates to the nucleus where, phosphorylated by AKT, it binds HIF-1\\u03b1 to drive PD-L1 transcription [#27], and functions as a switch from glycolysis to autophagy under substrate deprivation [#3]. STING directly inhibits HK2 enzymatic activity to restrict aerobic glycolysis and promote antitumor immunity, independent of innate immune signaling [#4].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that HK2 transcription is directly wired to nutritional state, defining the lipogenic transcription factor SREBP-1 as a direct activator of the HK2 promoter in metabolic tissues.\",\n      \"evidence\": \"In vivo ChIP and fasting/refeeding expression analysis in rat liver, adipose, and muscle\",\n      \"pmids\": [\"15627654\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not address protein-level or localization regulation\", \"Co-regulation with other nutrient-responsive factors not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed that HK2, uniquely among hexokinases, redistributes between cytosol and mitochondria during ischemic preconditioning, framing subcellular localization as a regulated functional variable.\",\n      \"evidence\": \"Subcellular fractionation and hexokinase activity assays in Langendorff-perfused rat hearts\",\n      \"pmids\": [\"19228992\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular trigger of redistribution not identified\", \"Consequences for cell survival not directly tested here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined mitochondrial HK2 as a glucose-sensing molecular switch governing cell fate and showed hypoxic recruitment of TIGAR potentiates its activity to limit ROS.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, ROS and cell death assays under hypoxia and glucose deprivation\",\n      \"pmids\": [\"22233811\", \"23185017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the HK2-PEA15 and HK2-TIGAR interactions unresolved\", \"Quantitative thresholds for switch behavior undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified AMPK and calcium/calcineurin-CaMK signaling as upstream transcriptional regulators linking metabolic and contractile signals to HKII expression in muscle.\",\n      \"evidence\": \"AICAR infusion in rats and pharmacological calcineurin/CaMK inhibition in skeletal muscle\",\n      \"pmids\": [\"12388122\", \"17516843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter-binding effectors downstream of these kinases not mapped\", \"Generalizability beyond muscle untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved how HK2 abundance is coupled to glucose supply, identifying it as a glucose-regulated chaperone-mediated autophagy substrate whose excessive degradation causes metabolic catastrophe.\",\n      \"evidence\": \"CMA-substrate proteomics, lysosomal fractionation, and genetic/pharmacological CMA manipulation\",\n      \"pmids\": [\"26323688\", \"26075878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between CMA and proteasomal turnover not quantified\", \"Autophagy-switch mechanism in cardiomyocytes mechanistically thin\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mechanistically linked Akt/GSK3\\u03b2 signaling to HK2 mitochondrial release, showing GSK3\\u03b2-driven VDAC phosphorylation dissociates HK2 to trigger apoptosis.\",\n      \"evidence\": \"HK2-VDAC Co-IP, phospho-VDAC blots, glycolysis and apoptosis assays with GSK3\\u03b2 activator/AKT inhibitor; p53/zinc context in prostate cancer\",\n      \"pmids\": [\"31669347\", \"30528266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"VDAC phosphosite specificity not fully mapped\", \"Single-lab pharmacological models\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Expanded the HK2 transcriptional network by showing oncogenic YAP/TEAD-p65 cooperation drives HK2 expression to promote migration, and subsequent studies added repressors and additional activators.\",\n      \"evidence\": \"Co-IP, ChIP at HK2 promoter, and reporter/migration assays; later ChIP studies of FOXE1, KLF14, ZNF281, Foxp1, PPAR\\u03b3/PER1, ATF4/HIF-1\\u03b1, CCT6A/STAT1\",\n      \"pmids\": [\"28945218\", \"31918722\", \"34983946\", \"36514923\", \"39083899\", \"22334075\", \"35255118\", \"37481013\", \"38750462\", \"22233811\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Hierarchy and combinatorial logic among these factors unresolved\", \"Most defined in single cancer/inflammation contexts\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established a layer of post-transcriptional and epitranscriptomic control of HK2, with m6A (METTL3), ac4C (NAT10), and nuclear pre-mRNA retention (FTO) tuning HK2 mRNA fate.\",\n      \"evidence\": \"m6A/ac4C sequencing, nuclear/cytoplasmic fractionation, and ubiquitination assays across cancer models\",\n      \"pmids\": [\"36403721\", \"39990211\", \"36075458\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of each RNA modification not compared\", \"Reader proteins for HK2 mRNA marks not all identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed non-canonical HK2 functions beyond glycolysis: a protein-kinase activity phosphorylating I\\u03baB\\u03b1 at Thr291 and nuclear HK2 binding HIF-1\\u03b1, both converging on NF-\\u03baB/HIF-driven PD-L1 to enable immune evasion.\",\n      \"evidence\": \"Site-directed mutagenesis, phosphorylation and Co-IP assays, PD-L1 reporters, and tumor specimen analysis\",\n      \"pmids\": [\"37377974\", \"37300724\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of HK2 protein-kinase activity undefined\", \"Substrate repertoire beyond I\\u03baB\\u03b1 unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined competing ubiquitin codes governing HK2 stability and localization\\u2014K48 ubiquitination (TRIM36, UBR7-Keap1 axis) drives degradation while CSN5 and K63-specific OTUD1 deubiquitination control abundance and mitochondrial residence.\",\n      \"evidence\": \"Linkage-specific ubiquitination assays, Co-IP, domain mapping, and in vivo KO models\",\n      \"pmids\": [\"36799474\", \"36419136\", \"31991125\", \"40500776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Coordination among these E3s/DUBs not integrated\", \"Cell-type specificity of each enzyme pair unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified STING as a direct enzymatic inhibitor of HK2, decoupling glycolytic restriction from innate immune signaling and connecting HK2 activity to antitumor immunity.\",\n      \"evidence\": \"In vitro hexokinase activity assays, STING manipulation, in vivo tumor models, and human CRC correlation\",\n      \"pmids\": [\"37443289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mode of STING-HK2 inhibition undefined\", \"Stoichiometry and reversibility not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected HK2-driven glycolysis to chromatin via lactate, showing HK2-generated lactate promotes H3K18 lactylation that feeds back to activate the HK2 promoter, forming a self-amplifying loop.\",\n      \"evidence\": \"HK2 knockout mice, Seahorse analysis, and ChIP for H3K18 lactylation at the HK2 promoter in renal ischemia-reperfusion\",\n      \"pmids\": [\"39217289\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single disease context\", \"Direct vs indirect lactylation effects on transcription not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HK2's canonical glycolytic, moonlighting protein-kinase, nuclear transcriptional, and mitochondrial death-switch functions are spatially and temporally coordinated within a single cell remains unresolved.\",\n      \"evidence\": \"No single study integrates these activities under defined physiological transitions\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model linking localization to non-canonical activities\", \"Quantitative partitioning of HK2 pools (cytosolic/mitochondrial/nuclear) undefined\", \"Causal hierarchy among the regulatory layers not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 6, 7, 8, 18, 32]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 11]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 5, 6, 18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 12, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 15, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"VDAC1\", \"PEA15\", \"TIGAR\", \"OTUD1\", \"STING\", \"CSN5\", \"TRIM36\", \"HIF-1\\u03b1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}